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Gingival  squamous  cell  carcinoma  (GSCC)  displays  strong  potential  for  local  inﬁltration.  Detailed  evalu-
ation  of bone  invasion  to the  mandible  is an  important  problem  clinically.  The  purpose  of  this  study was
to  investigate  the  expression  of  osteoclast-related  cytokines,  which  play  an  important  role  in mandibu-
lar  invasion.  A  total  of  23  cases  of  lower  GSCC  were  classiﬁed  histopathologically  as  non-invasive  group
(n  =  10)  or  invasive  group  (n =  13).  Cytokines  of  interleukin  (IL)-1,  IL-1,  IL-6, IL-11,  tumor  necrosis  factor
(TNF)-,  parathyroid  hormone-related  protein  (PTHrP),  receptor  activator  of  nuclear  factor  B  (RANK),
RANK  ligand  (RANKL),  and  osteoprotegerin  (OPG)  were  selected.  In  this  prospective  study,  the  expres-ingival squamous cell carcinoma
everse transcriptase-polymerase chain
eaction
sions  of  these  cytokines  were  studied  by  quantitative  real-time  reverse  transcription-polymerase  chain
reaction.  IL-1,  IL-1,  IL-6,  TNF-,  PTHrP,  and  RANKL  were  expressed  higher  in  the  invasive  group.  In  par-
ticular,  IL-6  was  considered  as  a  non-speciﬁc  cytokine  which  responds  to inﬂammatory  change  by  tumor
or  non-tumor  stimulation.  These  results  suggest  that  IL-1,  IL-1,  IL-6, TNF-,  PTHrP,  and  RANKL  play
important  roles  in  the  mechanisms  underlying  mandibular  invasion.  Furthermore,  expression  analysis
of  OPG/RANK/RANKL  system  may  contribute  to treatment  and  prevention  of  GSCC  in future.
 Japan© 2012
. Introduction
Gingival squamous cell carcinoma (GSCC) is a malignant tumor
hat frequency invades the maxilla and mandibular bone anatom-
cally [1,2]. Clinically, detailed evaluation of mandibular invasion
s important when deciding whether to perform mandibulectomy
ssociated with deterioration in the quality of life [3–5]. The extent
f mandibular invasion was only assessed by radiography such
s computed tomography (CT) and magnetic resonance imaging.
owever they do not always make a precise diagnosis [6–11].
In  several types of cancers, numerous studies have investigated
he functional mechanisms of osteoblasts and osteoclasts with var-
ous cytokines related to bone metastasis [1,12–14]. They also have
ocused on histopathological bone invasion caused by activation of
steoclast by osteoclast-related cytokines including interleukin-1
IL-1), interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-
1 (IL-11), tumor necrosis factor- (TNF-), and parathyroid
ormone-related protein (PTHrP) [15,16]. Furthermore they have
eported that osteoblasts might act on pre-osteoclasts and dif-
erentiation to osteoclasts is promoted by a pathway of the
steoprotegerin (OPG)/receptor activator of nuclear factor B
RANK)/RANK ligand (RANKL) system in vitro [17,18]. Although it
∗ Corresponding author. Tel.: +81 43 270 3977; fax: +81 43 270 3979.
E-mail  address: tanomura@tdc.ac.jp (T. Nomura).
348-8643/$ – see front matter ©  2012 Japanese Stomatological Society. Published by Els
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has been reported that the RANKL/RANK signaling pathway also
regulates bone invasion or metastasis in oral squamous cell carci-
noma (OSCC) cell lines, it remains unclear for human OSCC [18].
In addition, most reports have used a histopathological approach
in the clinical study design for the expression of those cytokines
[1,9–11,16].
The purpose of this study was to investigate the network system
of osteoclast-related cytokines in a prospective study, which play
important roles in mandibular invasion by human GSCC.
2.  Materials and methods
In  this prospective study, the subjects were 23 patients with
lower GSCC who underwent mandiblectomy at the Department
of Oral and Maxillofacial Surgery, Tokyo Dental College between
July 2004 and June 2007. Mean age (±S.D.) was 65.0 (±8.6) years.
There were 14 males and 9 females. Informed consent was  obtained
from each patient according to a protocol that was reviewed and
approved by the ethical review board of Tokyo Dental College.
2.1.  Clinicopathological analysis of mandibular invasionAccording to resection specimens, which were stained using
hematoxylin and eosin, tumors were classiﬁed histopathologically
into two groups as we have reported [16]. In the non-invasive
group, diffuse tumor cells were apparent near the mandible
evier Ltd. All rights reserved.
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Fig. 1. Twenty-three gingival squamous cell carcinoma cases were classiﬁed histopathologically into non-invasive and invasive groups (×50). (A) Non-invasive group: tumor
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aells  diffused near the mandible without invasion into bone. Fibrous connective t
nvading into bone with inﬁltration. Tumor cells have advanced independently into
ithout invasion into bone. Fibrous connective tissue was seen at
he border between tumor and bone. In the erosive type, tumor
ells were histopathologically identiﬁed directly adjacent to the
one surface, although the bone surface was clear, smooth and
ontinuous despite absence of an intervening layer of connective
issue. The invasive group, was deﬁned as Brown’s inﬁltrative type
ith tumor cells invading and inﬁltrating into bone and osteoclasts
ppearing along the bone surface [14,19,20]. Tumor cells advanced
ndependently into cancellous bone without an intervening layer
f connective tissue (Fig. 1).
.2. mRNA expression analysis
The  specimens were taken from the center of tumors at the
ime of surgical resection. After resection, each sample was  imme-
iately kept at −80 ◦C until analyzed. Total RNA samples were
repared using Trizol Reagent (Invitrogen, Carlsbad, CA, USA),
ccording to the protocols of the manufacturer. For gene expression
f 9 cytokines by quantitative real-time reverse transcription-
olymerase chain reaction (QRT-PCR), 2 g of total RNA was
everse-transcribed into cDNA using a one-step kit (ready-to-go
T-PCR Beads; GE Healthcare, Buckinghamshire, UK) and oligo
dT)12–18 primer (Invitrogen).
QRT-PCR  using the TaqMan MGB  probe (Applied Biosys-
ems, Foster City, CA, USA) was performed with modiﬁcations
o the manufacturer’s instructions [21–23]. GAPDH was used
s an internal control (Cat. No. 4333764F; Applied Biosystems).
aqMan MGB  probes of IL-1, IL-1, IL-6, IL-11, TNF-, PTHrP,
ANK, RANKL, and OPG were purchased from Applied Biosystems
Assay ID; Hs00174092 m1,  Hs00174097 m1,  Hs00174131 m1,
s00174148 m1,  Hs00174128 m1,  Hs00174969 m1,
s00187189 m1,  Hs00243522 m1,  and Hs00171068 m1,  respec-
ively). PCR reactions using the primer sets in an ABI PRISM 7700
equence Detector (Applied Biosystems) were performed in a ﬁnal
olume of 25 l of reaction mixture: 2 l of previously diluted
DNA, followed by addition of 1 l of 20× TaqMan primers and
robe and 10 l of TaqMan Universal Master Mix  (Applied Biosys-
ems), according to the manufacturer’s instructions. An initial
enaturation step was performed at 95 ◦C for 10 min, followed by
0 PCR cycles of denaturation at 95 ◦C for 15 s and annealing or
xtension at 60 ◦C for 1 min. ABI7700 system software was used to
onitor in FAM dye. Threshold cycle (Ct) value for each reactioneﬂects the amount of PCR needed to identify a target gene, and
he relative level of 9 cytokines for each sample was  calculated
s outlined by the manufacturer. GAPDH was used to normalize
mounts of cytokine mRNA. The Ct value was subtracted from thatwas seen at the border between tumor and bone. (B) Invasive group: tumor cells
llous bone without an intervening layer of connective tissue.
of the cytokine gene to obtain a Ct value. The difference (Ct)
between Ct of each sample for the gene target and Ct of the
calibrator was  determined. Specimens were analyzed 3 times and
values were averaged.
2.3.  Immunohistochemical staining
The cases of mRNA expression were studied by immunohisto-
chemical analysis. Selection samples were decalciﬁed, parafﬁnized,
and sectioned at 4 m thick. Sections were deparafﬁnized in xylene,
hydrated in graded ethanol, and then heated in the microwave
in 0.01 M sodium citrate solution at 60 ◦C for 20 min. To elimi-
nate endogenous peroxidase, sections were immersed in 3% H2O2
solution in methanol at room temperature for 15 min. Sections
were washed with phosphate-buffered saline (PBS; pH 7.4) for
15 min. Non-speciﬁc reactions were blocked by treatment with
10% normal rabbit serum at room temperature for 30 min. Sections
were incubated with primary antibodies diluted at 4 ◦C overnight.
Sections were then treated using secondary antibodies (biotin-
labeled mouse IgG, IgA, and IgM antibodies for IL-1, IL-1, PTHrP,
RANK, RANKL, and OPG and biotin-labeled goat antibodies for IL-6,
IL-11, and TNF-) at room temperature for 30 min. Thereafter, sec-
tions were immersed in peroxidase-labeled streptavidin at room
temperature for 30 min  (Histoﬁne SAB-PO Kit; Nichirei, Tokyo,
Japan). Color reaction was  performed using 3,3-diaminobenzidine-
4-hydrochloride Tris–HCI buffer containing 0.05% H2O2 solution for
5 min, Mayer’s comparative staining with hematoxylin was per-
formed, and specimens were examined under microscopy at ×400.
Specimens treated with PBS alone instead of with the primary
antibodies were used as negative controls, and specimens with
more pronounced staining reaction in the cytoplasm than negative
controls were classed as antibody-positive.
2.4. Statistical analysis
Mann–Whitney’s U-test and Chi-square test were performed to
evaluate correlations between the non-invasive and the invasive
groups. Values of p < 0.05 were considered statistically signiﬁcant.
3. Results
3.1. Clinicopathological analysisFrom the resection specimens of these cases, tumors were
grouped by microscopic examination into 10 cases in the non-
invasive group and 13 cases in the invasive group. Patients
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Table  1
Primary antibody for immunohistochemical staining of 6 cytokines related to osteoclasts.
Cytokine Primary antibody Marker Dilution ratio
IL-1alpha Rabbit anti-human IL-1 polyclonal antibody ENDOGEN 1/100
IL-1beta Rabbit anti-human IL-1 polyclonal antibody ENDOGEN 1/100
IL-6 Goat  anti-human IL-6 polyclonal antibody Santa Cruz Biotechnology 1/100
R&D Systems 1/100
y CALBIOCHEM 1/100
y R&D Systems 1/100
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Table 2
Clinicopathological analysis in mandibular invasion.
Non-invasion group Invasion group p-value
Number of patients (N) 10 13
Sex
Male 6 8
Female 4 5 0.943
Age  (±S.D.) 62.8 ± 8.7 66.7 ± 8.4 0.29
T1–T2  5 5
T3–T4 5 8 0.747
N  (−) 2 2
N (+) 8 11 0.277
Differentiation
Mild  4 6
F
i
s
RTNF-alpha Goat anti-human TNF- polyclonal antibody 
PTHrP Mouse anti-human PTHrP monoclonal antibod
RANKL Mouse anti-human RANKL monoclonal antibod
omprised 6 males and 4 females in the non-invasive group, and
 males and 5 females in the invasive group. Mean age (±S.D.) was
2.8 (±8.7) years in the non-invasive group and 66.7 (±8.4) years
n the invasive group. According to Union for International Can-
er Control classiﬁcations [19], the non-invasive group was  T1–T2
n 5 cases and T3–T4 in 5 cases. In contrast, the invasive group
as T1–T4 in 5 cases and T3–T4 in 8 cases. Furthermore N posi-
ive cases consisted of 8 cases in the non-invasive group and 11
ases in the invasive group. According to tumor differentiation,
he non-invasive group included 4 cases with mildly differenti-
ted, 4 cases with moderately differentiated, and 2 cases with
oorly differentiated cells. In contrast, the invasive group included
 cases with mildly differentiated and 7 cases with moderately
ifferentiated cells. For all clinical data, there were no signiﬁcant
ifferences between the non-invasive group and the invasive group
y Mann–Whitney’s U-test and Chi-square test (Table 1).
.2.  mRNA expression analysis
In  the non-invasive group, mean mRNA expression levels
Ct value) were 0.07 (range, 0.0–0.33) for IL-1, 0.34 (range,
.0006–2.46) for IL-1, 117.93 (range, 0.55–519.15) for IL-6,
7.70 (range, 8.54–32.75) for TNF-, 1.09 (range, 0.08–4.05) for
THrP, and 16.44 (range, 2.49–34.66) for RANKL. In the invasive
roup, mean mRNA expression was 14.78 (range, 0.002–161.27)
or IL-1, 41.68 (range, 0.04–492.28) for IL-1, 612.28 (range,
.14–6137.07) for IL-6, 31.58 (range, 1.00–174.65) for TNF-, 4.74
range, 0.09–21.96) for PTHrP, and 58.01 (range, 1.01–278.20) for
ANKL [IL-1 (p = 0.277), IL-1 (p = 0.099), IL-6 (p = 0.849), TNF-
p = 0.425), PTHrP (p = 0.086), and RANKL (p = 0.558)]. Though these
ig. 2. Expression of 9 cytokines related to osteoclasts in resection specimens by real-tim
nvasive and invasive groups. Y-axis means the threshold cycle (Ct) value difference be
oftware. Values of p < 0.05 were considered signiﬁcant (Mann–Whitney’s U-test). IL; inte
ANK, receptor activator of nuclear factor B; RANKL, RANK ligand; OPG, osteoprotegerinModerately 4 7
Poorly 2 0 0.349
expressions were not signiﬁcant, the mRNA expression of IL-1, IL-
1, IL-6, TNF-, PTHrP, and RANKL was higher in the invasive group
than in the non-invasive group. In particular, the expression of IL-6
was  higher. IL-11, RANK, and OPG were not expressed (Fig. 2).
3.3. Immunohistochemical staining
We observed immunohistochemical staining for 6 cytokines
including IL-1, IL-1, IL-6, TNF-, PTHrP, and RANKL because of
the high values of mRNA expression in the invasive group. Six anti-
bodies were used in some cases of each group (Table 2). There
was more positive staining in cells for IL-1, IL-1, IL-6, TNF-,
PTHrP, and RANKL in the invasive cases than in the non-invasive
cases (Fig. 3). In each specimen, positive cells of these cytokines
e quantitative polymerase chain reaction. Results were compared between non-
tween that of each cytokine gene and that of the calibrator by ABI7700 system
rleukin; TNF, tumor necrosis factor; PtHRP, parathyroid hormone-related protein;
. : non-invasive group; : invasive group; NE: no expression.
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Fig. 3. Immunohistochemical staining for expression of 6 cytokines related to osteoclasts in resection specimens (×200). (A) IL-1: non-invasive group; (B) IL-1: invasive
group; (C) IL-1: non-invasive group; (D) IL-1: invasive group; (E) IL-6: non-invasive group; (F) IL-6: invasive group; (G) TNF-: non-invasive group; (H) TNF-: invasive
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tHRP, parathyroid hormone-related protein; RANKL, receptor activator of nuclear 
ere observed on not only bone surface but also distant from
one. In the invasive group an increased number of osteoclasts
t the tumor/bone interface was mostly observed microscopi-
ally (Figs. 1 and 3). Most immunohistochemical staining revealed
ositive-stained cells in the specimens as follows: IL-1, lympho-
yte; IL-1, IL-6, and TNF-, lymphocyte and tumor cell; PTHrP,
umor cells; RANKL, stromal cell-like cell. The expressions of these
ytokines revealed both positive-stained cytoplasm and nuclei in
he tumor cells.
.  Discussion
Bone resorption by osteoclasts is an important step in the pro-
ess of bone invasion and bone metastasis for several types of
uman cancers including renal cancer, breast cancer, and mul-
iple myeloma [22,23]. Furthermore, we have previously shown
hat human OSCC causing mandibular invasion was also found to
elease osteoclast-related cytokines including IL-6, IL-11, TNF-,
nd PTHrP [16]. From clinical data in this study, there were no clear
orrelations between differentiation type which showed general
valuation of malignancy and mandibular invasion type in human
SCC. As a result, the present study focused attention on cytokines
hat reportedly contribute to bone invasion and bone metastasis
or several types of cancers [15,16,22,23]: IL-1, IL-1, IL-6, IL-
1, TNF-, PTHrP, RANK, RANKL, and OPG. In QRT-PCR, levels of
L-1, IL-1, IL-6, TNF-, PTHrP, and RANKL mRNA were clearly,
ut non-signiﬁcantly, higher in the invasive group. Moreover, the
RNA expression level of IL-6 appeared greatly higher in the inva-
ive group. In the meantime IL-6 mRNA expression level varied
reatly in each case and the range was wider. This is because IL-6 is
 multifunctional cytokine including inﬂammatory change with aive group; (L) RANKL: invasive group. IL; interleukin; TNF, tumor necrosis factor;
 B ligand.
strong nonspeciﬁc reaction and is affected by various mechanisms,
unlike the other cytokines [13,15]. In vitro, some human OSCC cell
lines are known to produce osteoclast-related cytokines including
inﬂammatory cytokines such as IL-1, IL-1, and IL-6 [15,18,24]. In
comparison, PTHrP and RANKL are known to be activated speciﬁ-
cally in pre-osteoclasts and osteoclasts [18,25,26]. For IL-11, RANK,
and OPG, no expression was  identiﬁed by QRT-PCR. On  the other
hand, there are some reports indicating that IL-11, RANK, and OPG
are important in the process of bone invasion in several cancers. It
was  also reported that positive rate of immunohistochemical stain-
ing for RANK was not signiﬁcantly higher in bone-invasive OSCC
than in non-invasive OSCC. IL-11, RANK, and OPG  may  not con-
tribute to the mandibular invasion of GSCC. Furthermore, in bone
invasive OSCC, the positive rate of immunohistochemical staining
for RANK was  not signiﬁcantly higher than in non-invasive OSCC
[27]. Our study is also similar. However, it is not clear about the
difference between OSCC and the other cancers. Even if no clear
signiﬁcant difference was found in expression, IL-1, IL-1, IL-6,
TNF-, PTHrP, and RANKL may  play important roles in the mech-
anism of mandibular invasion by GSCC. Generally the pathways
of these cytokines are very complex. IL-1 and IL-1 have been
reported as playing a prominent role in enhancing transcription
and expression of inﬂammatory cytokines such as IL-6 [24,25]. IL-
1, IL-6, TNF-, and PTHrP have been shown to activate osteoclasts
and PTHrP activates osteoblasts to up-regulate RANKL expression
[18,26]. RANKL then binds to RANK expressed in pre-osteoclasts
and promotes differentiation to mature osteoclasts [17,18]. This
cycle results in the development and progression of bone invasion
and bone metastasis. OPG inhibits the differentiation and activity of
osteoclasts, which is a decoy receptor of RANKL. In this study, PTHrP
and RANKL might be the starting point of the OPG/RANK/RANKL
system expressed in a bone resorption process. IL-1, IL-1, IL-6,
2 nce In
a
C
a
i
c
d
o
c
s
o
r
o
s
m
c
i
C
A
P
t
i
a
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[4 S. Matsubara et al. / Oral Scie
nd TNF- might reinforce activation of osteoclasts by this system.
onsequently, inhibition of RANK/RANKL system is expected to be
 theraupeutic target to prevent bone invasion by GSCC. The local-
ty of these cytokines was also the subject of attention. Positive
ells for each cytokine were observed both on the bone surface and
istant from bone by immunohistochemical staining. Expression
f these cytokines thus did not seem to depend on the locus, and
ytokines were delivered directly from OSCC cells. Potentially, even
mall biopsy samples of GSCC may  allow evaluation of the degree
f bone invasion according to expression of these cytokines.
In  conclusion, our study suggests that human GSCC cells
eleased IL-1, IL-1, IL-6, TNF-, PTHrP, and RANKL, which are
steoclast-related cytokines and activity of the OPG/RANK/RANKL
ystem ﬁnally caused mandibular invasion. Understanding the
echanisms of the cytokine network in detail will be necessary to
ontribute to treatment and prevention of bone invasion by GSCC
n the future.
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